EKTTITAB Stock Overview
Ekttitab Holding Company K.S.C Public, together with its subsidiaries, engages in the investment activities in Kuwait.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Ekttitab Holding Company K.S.C Public Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | د.ك0.019 |
| 52 Week High | د.ك0.03 |
| 52 Week Low | د.ك0.0088 |
| Beta | 0.69 |
| 1 Month Change | -1.04% |
| 3 Month Change | 1.06% |
| 1 Year Change | 103.19% |
| 3 Year Change | -12.79% |
| 5 Year Change | 12.35% |
| Change since IPO | -94.94% |
Recent News & Updates
Recent updates
Shareholder Returns
| EKTTITAB | KW Capital Markets | KW Market | |
|---|---|---|---|
| 7D | 0% | 0.07% | 0.7% |
| 1Y | 103.2% | 19.2% | 1.7% |
Return vs Industry: EKTTITAB exceeded the KW Capital Markets industry which returned 19.4% over the past year.
Return vs Market: EKTTITAB exceeded the KW Market which returned 1.1% over the past year.
Price Volatility
| EKTTITAB volatility | |
|---|---|
| EKTTITAB Average Weekly Movement | 7.5% |
| Capital Markets Industry Average Movement | 5.2% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in KW Market | 10.8% |
| 10% least volatile stocks in KW Market | 2.2% |
Stable Share Price: EKTTITAB has not had significant price volatility in the past 3 months.
Volatility Over Time: EKTTITAB's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of KW stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | n/a | Muhammad Al-Ayyoob | www.ektettab.com |
Ekttitab Holding Company K.S.C Public, together with its subsidiaries, engages in the investment activities in Kuwait. The company was founded in 1999 and is headquartered in Kuwait City, Kuwait.
Ekttitab Holding Company K.S.C Public Fundamentals Summary
| EKTTITAB fundamental statistics | |
|---|---|
| Market cap | د.ك6.09m |
| Earnings (TTM) | -د.ك157.65k |
| Revenue (TTM) | د.ك720.00 |
8,452x
P/S Ratio-38.6x
P/E RatioIs EKTTITAB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EKTTITAB income statement (TTM) | |
|---|---|
| Revenue | د.ك720.00 |
| Cost of Revenue | د.ك0 |
| Gross Profit | د.ك720.00 |
| Other Expenses | د.ك158.37k |
| Earnings | -د.ك157.65k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00049 |
| Gross Margin | 100.00% |
| Net Profit Margin | -21,895.83% |
| Debt/Equity Ratio | 0% |
How did EKTTITAB perform over the long term?
See historical performance and comparison